Literature DB >> 6478396

Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.

H Kato, K Tamai, H Morioka, M Nagai, T Nagaya, T Torigoe.   

Abstract

A radioimmunoassay for a tumor-antigen (TA-4) of squamous cell carcinoma was used to detect the recurrence in patients with squamous cell carcinoma of the uterine cervix. Of 17 patients who had recurrence, 15 cases showed reappearance of serum TA-4 levels. Reappearance of serum TA-4 was faster than other clinical signs of recurrence in 11 cases. These results indicated that TA-4 assay would be a useful aid for the detection of recurrence in cervical squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478396     DOI: 10.1002/1097-0142(19841015)54:8<1544::aid-cncr2820540813>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Squamous cell carcinoma antigen levels in patients with different stages of laryngeal cancer.

Authors:  G Namyslowski; J Klimala; D Kokocinska; M Misiolek
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

2.  Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.

Authors:  H Kanazawa; M Ebina; N Ino-Oka; M Shimizukawa; T Takahashi; S Fujimura; T Imai; T Nukiwa
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

3.  An immunoradiometric assay of tumour-antigen 4 (TA-4): a comparison with conventional radioimmunoassay.

Authors:  N Mino-Miyagawa; Y Kimura; K Hamamoto
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

4.  Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.

Authors:  G Kenter; J M Bonfrer; A P Heintz
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

5.  Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignancies.

Authors:  G Scambia; P Benedetti Panici; L Perrone; C Sonsini; S Giannelli; A Gallo; P G Natali; S Mancuso
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

6.  A comparison of serum CYFRA 21-1 and SCC Ag in the diagnosis of squamous cell lung carcinoma.

Authors:  Y C Kim; K O Park; I S Choi; H J Kim; S C Lim; H S Bom
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

7.  Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach.

Authors:  S Ozawa; M Ueda; N Ando; O Abe; N Shimizu
Journal:  Jpn J Cancer Res       Date:  1988-11

8.  Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand.

Authors:  Chen-Tzu Chiu; Pei-Wen Wang; Meshach Asare-Werehene; Benjamin K Tsang; Dar-Bin Shieh
Journal:  Cancers (Basel)       Date:  2020-06-13       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.